ATXS•benzinga•
Wedbush Maintains Outperform on Astria Therapeutics, Raises Price Target to $28
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 12, 2025 by benzinga